November 7th 2025
Protein METTL7A plays key role in resistance to drugs targeting EGFR-mutant lung adenocarcinoma.
October 28th 2025
Yale Cancer Center researchers publish promising study of dual inhibition of PD1 and macrophage migration inhibitory factor.
October 20th 2025
October 14th 2025
Researchers developed a way to predict how lung cancer cells will respond to different therapies, allowing for more effective individualized treatment.
September 23rd 2025
Tracy Battaglia, MD, MPH, joined Yale Cancer Center’s Community Outreach and Engagement as associate director.
September 9th 2025
A Yale study published identified the mechanism underlying the relationship between the development of AMKL and a specific genetic alteration that occurs.
August 26th 2025
New tool by Yale researchers charts journey from pre-cancerous to advanced disease in animal models.
July 23rd 2025
More than 2 dozen Yale experts are collaborating on a therapy for the most defended tumors.
July 16th 2025
A Yale study found that open-source AI tools outperformed traditional, visual methods for measuring the abundance of melanoma biomarkers.
July 9th 2025
Collaborative study investigates the unique immune features of rare cancer type, says Yale's David Braun, MD, PhD.
June 25th 2025
Yale School of Medicine announced the opening of the Yale Biomedical Imaging Institute, uniting imaging, clinical translation, and data science.
February 6th 2025
Yale Medicine was ranked third in the nation for physician practices, an annual designation by Castle Connolly.
July 14th 2024
Natural killer cells hold promise for treating cancer; Yale researchers have found a way to overcome their main limitation.
April 9th 2024
Yale Cancer Center will share data for breakthrough and emerging cancer treatments at the AACR Annual Meeting.
March 25th 2024
Amer Zeidan, MBBS, MHS, has been appointed inaugural chief of the Division of Hematologic Malignancies at Yale Cancer Center.
February 5th 2024
Non-small cell lung cancer, with an EGFR mutation, tends not to respond well to immunotherapy treatments, including durvalumab.
January 12th 2024
Although use of immunotherapy near the end of life has increased over time, a closer look at the benefit of this in those with advanced cancers is needed.
October 17th 2023
A new study led by Yale scientists shows that the activity of a portion of a human papillomavirus protein does not depend on its amino acid sequence or composition.
May 24th 2023
Yale Cancer Center and Smilow Cancer Hospital scientists and clinicians will present new research at the 2023 Annual Meeting of the American Society of Clinical Oncology, June 2nd to June 6th at McCormick Place in Chicago, Illinois.
February 8th 2023
Age-based heuristics can lead to large differences in breast cancer treatment based on small differences in chronologic age, according to a new analysis of more than 500,000 patient records.